Alaunos Therapeutics | ZIOP - Betriebsaufwand

Aktienkurs
2.76
Täglich Wechseln
0 0%
Monatlich
-8.31%
Jährlich
4.94%
Q2 Prognose
2.70




Betriebsaufwand Veränderung Datum
Alaunos Therapeutics USD 1.19M 148K 2025-09
Amgen USD 5.9B 773M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Biogen USD 1.88B 81.4M 2025-09
Bioline Rx USD 2.63M 24K 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Celltrion KRW 724.99B 6B 2025-09
Corcept Therapeutics USD 197.64M 219K 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Curis USD 9.02M 23.01M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
J&J USD 17.44B 1.53B 2026-03
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Merck USD 10.16B 558M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Novartis USD 9.8B 61M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pfizer USD 12.91B 79.89B 2025-12
Pharma Mar EUR 46.87M 7.24M 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
TG Therapeutics USD 142.08M 9.74M 2025-12
Tilray USD 237.52M 17.34M 2025-09
Verastem USD 59.01M 21.98M 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09